The MAX19707 is an ultra-low-power, mixed-signal analog front-end (AFE) designed for power-sensitive communication equipment. Optimized for high dynamic
performance at ultra-low power, the device integrates a dual, 10-bit, 45Msps receive (Rx) ADC; dual, 10-bit, 45Msps transmit (Tx) DAC; three fast-settling 12-bit aux-DAC channels for ancillary RF front-end control; and a 10-bit, 333ksps housekeeping aux-ADC. The typical operating power in Tx-Rx FAST mode is 84.6mW at a 45MHz clock frequency.
The Rx ADCs feature 54.2dB SNR and 71.2dBc SFDR at fIN = 5.5MHz and fCLK = 45MHz. The analog I/Q input amplifiers are fully differential and accept 1.024VP-P full-scale signals. Typical I/Q channel matching
is ±0.03° phase and ±0.01dB gain.
The Tx DACs feature 73.2dBc SFDR at fOUT = 2.2MHz and fCLK = 45MHz. The analog I/Q full-scale output voltage is ±400mV differential. The Tx DAC common-mode DC level is programmable from 0.71V to 1.05V. The I/Q
channel offset is programmable to optimize radio lineup sideband/carrier suppresion. The typical I/Q channel matching is ±0.01dB gain and ±0.07° phase.
The Rx ADC and Tx DAC share a single, 10-bit parallel, high-speed digital bus allowing half-duplex operation for time-division duplex (TDD) applications. A 3-wire serial interface controls power-management modes, the aux-DAC channels, and the aux-ADC channels.
The MAX19707 operates on a single 2.7V to 3.3V analog supply and 1.8V to 3.3V digital I/O supply. The MAX19707 is specified for the extended (-40°C to
+85°C) temperature range and is available in a 48-pin, thin QFN package. The Selector Guide at the end of the data sheet lists other pin-compatible versions in this AFE family.
Notes: **This pricing is BUDGETARY, for comparing similar parts. Prices are in
U.S. dollars and subject to change. Quantity pricing may vary
substantially and international prices may differ due to local
duties, taxes, fees, and exchange rates. For volume-specific prices
and delivery, please see the price and availability page
or contact an authorized distributor.